November 7, 2011
RESEARCH TRIANGLE PARK, N.C.--Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory. Now known as Advion Bioanalytical Labs, a Quintiles company, the group provides Good Laboratory [...]
Oxford Expression Technologies launches US hub
November 7, 2011
San Diego, CA, USA - Oxford Expression Technologies (OET), the award-winning specialist provider of recombinant protein expression solutions, has opened a new US hub site. The inauguration of this new hub, which is operated by San Diego based biotech company Abcore Inc, will not only allow customers in the United States to purchase OET products [...]
Dr. Albert Luderer Joins BioNano Genomics Board of Directors
November 7, 2011
SAN DIEGO--BioNano Genomics, Inc. has elected Albert Luderer, Ph.D., to its Board of Directors. Dr. Luderer brings to the role more than three decades of experience in biotechnology, with a special emphasis on technology and business development and commercialization. The appointment supports the Company’s ongoing commitment to delivering new technologies that provide researchers with an [...]
November 7, 2011
SANTA CLARA, Calif., Agilent Technologies Inc. (NYSE: A) today launched the Agilent 2200 TapeStation to automate next-generation sequencing sample and library quality control. Together with the prepackaged, ready-to-use ScreenTape consumables, the 2200 TapeStation simplifies and accelerates quality control in the next-gen sequencing workflow. "We are very excited about this launch," said Patrick Kaltenbach, vice president [...]
November 7, 2011
Abcodia, a specialist company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases and Oxford Gene Technology (OGT) a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced a collaboration aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia [...]
November 7, 2011
TUSTIN, Calif. – Symbion Systems, Inc., a leader in providing analytical instrument control, analysis, and connectivity software, today announced the release of its SII-K02 second generation driver for the Kaiser Optical Systems, Inc. suite of RamanRxn Systems analyzers. The new driver is designed to function in concert with the latest generation (Version 5.0) of Kaiser [...]
November 7, 2011
TUSTIN, Calif. – Symbion Systems, Inc., a leader in providing analytical instrument control, analysis, and connectivity software, today announced that its Symbion-DX, RX, and LX Analytical Instrument Software Suites, Version 5.0, are now fully compatible with all versions of the Windows 7™ operating system. As a result, the Symbion Analytical Instrument Software Suites can now [...]
November 7, 2011
Cambridge, UK - Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support the development of personalized medicines, announces a strategic partnership agreement with Promega Corporation, the leader in innovative life science research technologies. The partnership centers on the delivery of endogenous gene reporting capabilities, in the form of Promega’s luciferase and HaloTag® [...]
Thermo Fisher Scientific Maximizes Cold Storage Capacity
November 7, 2011
MILFORD, Mass. - Thermo Fisher Scientific Inc., the world leader in serving science, recently introduced its portfolio of Thermo Scientific Revco UxF Series ultra-low temperature (ULT) freezers. Available in five sizes, with capacities from 421 to 949 liters (14.9 – 33.5 cubic feet), internal space is maximized, within a small laboratory footprint. In addition, the [...]
NanoString Secures $20M in Series D Financing
November 7, 2011
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing. New investors include GE, BioMed Ventures and Henri Termeer, former Chairman and CEO of Genzyme Corporation. All previous venture investors [...]

